Article info

Download PDFPDF

Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?
Free
  1. Correspondence to:
 Dr S Leibl
 Department of Pathology, Medical University of Graz, Auenbruggerplatz 25, A-8036 Graz, Austria; sebastian.leiblklinikum-graz.at
View Full Text

Citation

Leibl S, Moinfar F
Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?

Publication history

  • Accepted January 5, 2005
  • First published June 23, 2005.
Online issue publication 
June 23, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.